AU4833993A - Benzenesulfonamide derivative and use thereof - Google Patents

Benzenesulfonamide derivative and use thereof Download PDF

Info

Publication number
AU4833993A
AU4833993A AU48339/93A AU4833993A AU4833993A AU 4833993 A AU4833993 A AU 4833993A AU 48339/93 A AU48339/93 A AU 48339/93A AU 4833993 A AU4833993 A AU 4833993A AU 4833993 A AU4833993 A AU 4833993A
Authority
AU
Australia
Prior art keywords
methyl
phenyl
chlorophenylsulfonylamino
butyrate
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU48339/93A
Other languages
English (en)
Inventor
Yasuo Ito
Hideo Kato
Nobuo Ogawa
Shunichiro Sakurai
Tomio Suzuki
Shingo Yasuda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Japan Co Ltd
Original Assignee
Hokuriku Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hokuriku Pharmaceutical Co Ltd filed Critical Hokuriku Pharmaceutical Co Ltd
Publication of AU4833993A publication Critical patent/AU4833993A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
    • C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/19—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU48339/93A 1992-10-01 1993-09-29 Benzenesulfonamide derivative and use thereof Abandoned AU4833993A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP4-284938 1992-10-01
JP28493892 1992-10-01
JP16504193 1993-06-11
JP5-165041 1993-06-11
PCT/JP1993/001382 WO1994007848A1 (en) 1992-10-01 1993-09-29 Benzenesulfonamide derivative and use thereof

Publications (1)

Publication Number Publication Date
AU4833993A true AU4833993A (en) 1994-04-26

Family

ID=26489927

Family Applications (1)

Application Number Title Priority Date Filing Date
AU48339/93A Abandoned AU4833993A (en) 1992-10-01 1993-09-29 Benzenesulfonamide derivative and use thereof

Country Status (8)

Country Link
US (1) US5597848A (US20100012521A1-20100121-C00001.png)
EP (1) EP0663392A4 (US20100012521A1-20100121-C00001.png)
JP (1) JPH0753505A (US20100012521A1-20100121-C00001.png)
KR (1) KR950703522A (US20100012521A1-20100121-C00001.png)
AU (1) AU4833993A (US20100012521A1-20100121-C00001.png)
CA (1) CA2144780A1 (US20100012521A1-20100121-C00001.png)
TW (1) TW245638B (US20100012521A1-20100121-C00001.png)
WO (1) WO1994007848A1 (US20100012521A1-20100121-C00001.png)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0948775A (ja) * 1995-06-02 1997-02-18 Hokuriku Seiyaku Co Ltd （２−チエニル）アルカン酸誘導体
JPH10195038A (ja) * 1996-11-13 1998-07-28 Hokuriku Seiyaku Co Ltd ベンゼンスルホンアミド誘導体及びそれを含有する医薬
DE69805973T2 (de) * 1997-01-31 2002-12-19 The Board Of Trustees Of The Leland Stanford Junior University, Palo Alto Behandlung von herzrythmusstörungen durch hemmung einer multifunktionalen calcium/calmodulin-abhängigen protein kinase
FR2827280B1 (fr) * 2001-07-13 2003-10-31 Servier Lab Nouveaux derives de benzene sulfonamide, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JP2005533830A (ja) * 2002-07-09 2005-11-10 ビー．エム．アール．エイ． コーポレイション ベスローテン フェンノートシャップ トロンボキサンａ２受容体アンタゴニストおよびｃｏｘ−２阻害剤の薬剤の組み合わせ
US20050059741A1 (en) * 2003-08-07 2005-03-17 B.M.R.A. Corporation B.V. Compositions and methods involving the combination of a thromboxane A2 receptor antagonist and an inhibitor of cyclooxygenase-1
ITMI20061297A1 (it) * 2006-07-04 2008-01-05 Laboratorio Chimico Int Spa Procedimento per la preparazione della'acido (r)-(-)-3-(carbamoilmetil)-5-metilesanoico e del pregabalin e intermedi di sintesi
WO2009089098A1 (en) 2008-01-03 2009-07-16 Musc Foundation For Research Development Methods for the treatment of cancers

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2809377A1 (de) * 1978-03-04 1979-09-13 Boehringer Mannheim Gmbh Phenoxyalkylcarbonsaeure-derivate, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
DE3000377A1 (de) * 1980-01-07 1981-07-09 Boehringer Mannheim Gmbh, 6800 Mannheim Neue sulfonamide, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
DE3535167A1 (de) * 1985-10-02 1987-04-09 Boehringer Mannheim Gmbh Neue sulfonyl-phenyl(alkyl)amine, verfahren zu ihrer herstellung sowie arzneimittel
DE3821540A1 (de) * 1988-06-25 1989-12-28 Boehringer Mannheim Gmbh Neue sulfonamide, verfahren zu ihrer herstellung sowie solche sulfonamide enthaltende arzneimittel
DE3829455A1 (de) * 1988-08-31 1990-03-15 Boehringer Mannheim Gmbh Sulfonamidoalkyl-cyclohexan-verbindungen, verfahren zu ihrer herstellung sowie arzneimittel

Also Published As

Publication number Publication date
US5597848A (en) 1997-01-28
EP0663392A4 (en) 1995-09-13
WO1994007848A1 (en) 1994-04-14
CA2144780A1 (en) 1994-04-14
TW245638B (US20100012521A1-20100121-C00001.png) 1995-04-21
EP0663392A1 (en) 1995-07-19
KR950703522A (ko) 1995-09-20
JPH0753505A (ja) 1995-02-28

Similar Documents

Publication Publication Date Title
KR100688740B1 (ko) 프로테아제 억제제로서의 ｎ-시아노메틸 아미드
AU773273B2 (en) Novel sulfonamide compounds and uses thereof
JP4358908B2 (ja) 置換（アリール、ヘテロアリール、アリールメチル又はヘテロアリールメチル）ヒドロキサム酸化合物
DE60014588T2 (de) Thioamidderivate
AU779177B2 (en) Novel compounds and compositions as protease inhibitors
MXPA02002873A (es) Compuestos y composiciones farmaceuticas como inhibidores de la catepsina s.
NZ531153A (en) Carboxylic acid derivative compounds and drugs comprising these compounds as the active ingredient
TW201716375A (zh) 抗菌劑
CA2584610A1 (en) Novel dicarboxylic acid derivatives
AU4833993A (en) Benzenesulfonamide derivative and use thereof
DE69414194T2 (de) Aminosäurederivate und ihre Verwendung als Enkephalinase-Inhibitoren
AU716395B2 (en) Benzenesulfonamide derivatives and medicaments comprising said derivatives
JP2920741B2 (ja) 新規１，３−ジアルキルウレア誘導体
US20040147503A1 (en) Novel compounds and compositions as cathepsin inhibitors
NL1028559C2 (nl) Verbindingen die bruikbaar zijn voor de behandeling van ziekten
DE60205035T2 (de) Zur behandlung von autoimmunerkrankungen und allergien geeignete sulfonderivate
MXPA99004391A (en) Benzenesulfonamide derivatives and drugs containing the same
HU218963B (hu) Retinoidszerű vegyületek és ezeket tartalmazó gyógyszerkészítmények
EA010133B1 (ru) Производные формамида, пригодные в качестве адренорецептора
HU197880B (en) Process for producing 4-hydroxy-4-/substituted alkenyl/-cyclohexan-carboxylic acid derivatives
AU2002312357A1 (en) Novel compounds and compositions as cathepsin inhibitors
WO2002098406A1 (en) Novel compounds and compositions as cathepsin inhibitors
EP1452522A2 (en) Novel compounds and compositions as protease inhibitors
MXPA06010257A (en) Compounds useful for the treatment of diseases